Marco A Ramirez-Ortiz Selected Research

Tetrahydrofolate Dehydrogenase (Dihydrofolate Reductase)

12/2012

Risk of retinoblastoma is associated with a maternal polymorphism in dihydrofolatereductase (DHFR) and prenatal folic acid intake.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Marco A Ramirez-Ortiz Research Topics

Disease

3	Retinoblastoma (Glioblastoma, Retinal) 01/2017 - 12/2012
1	Orbital Cellulitis 01/2022
1	Glaucoma 01/2022
1	Hemorrhage 01/2022
1	Neoplasm Metastasis (Metastasis) 01/2021
1	Neoplasms (Cancer) 12/2020
1	Carcinogenesis 12/2012
1	Trachoma 11/2007
1	Conjunctivitis 11/2007
1	Wounds and Injuries (Trauma) 06/2007
1	Scleritis (Episcleritis) 06/2007

Drug/Important Bio-Agent (IBA)

1	4- chloro- 3',6'- dimethyl- 2,2'- iminodibenzoate (TO 115)IBA 01/2017
1	Messenger RNA (mRNA)IBA 12/2016
1	Transcription Factors (Transcription Factor)IBA 12/2016
1	A 19IBA 12/2012
1	CytosineIBA 12/2012
1	Folic Acid (Vitamin M)FDA LinkGeneric 12/2012
1	NucleotidesIBA 12/2012
1	Tetrahydrofolate Dehydrogenase (Dihydrofolate Reductase)IBA 12/2012
1	ThymineIBA 12/2012
1	Methylenetetrahydrofolate Reductase (NADPH2) (Methylenetetrahydrofolate Reductase)IBA 12/2012
1	Ophthalmic Solutions (Eye Drops)IBA 11/2007
1	Povidone-Iodine (Betadine)FDA LinkGeneric 11/2007
1	Chloramphenicol (Chloromycetin)FDA Link 11/2007
1	SteroidsIBA 06/2007

Therapy/Procedure

1	Drug Therapy (Chemotherapy) 01/2022
1	Radiotherapy 01/2021
1	Brachytherapy 12/2020
1	Therapeutics 01/2017